Annual Accounts Receivable
$447.00 K
-$39.60 M-98.88%
December 31, 2024
Summary
- As of March 12, 2025, AMLX annual accounts receivable is $447.00 thousand, with the most recent change of -$39.60 million (-98.88%) on December 31, 2024.
- During the last 3 years, AMLX annual accounts receivable has risen by +$447.00 thousand (+100.00%).
- AMLX annual accounts receivable is now -98.88% below its all-time high of $40.05 million, reached on December 31, 2023.
Performance
AMLX Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$447.00 K
-$1.28 M-74.18%
December 31, 2024
Summary
- As of March 12, 2025, AMLX quarterly accounts receivable is $447.00 thousand, with the most recent change of -$1.28 million (-74.18%) on December 31, 2024.
- Over the past year, AMLX quarterly accounts receivable has dropped by -$39.60 million (-98.88%).
- AMLX quarterly accounts receivable is now -98.88% below its all-time high of $40.05 million, reached on December 31, 2023.
Performance
AMLX Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
AMLX Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -98.9% | -98.9% |
| 3 y3 years | +100.0% | -98.5% |
| 5 y5 years | - | -98.5% |
AMLX Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -98.9% | -100.0% | -98.9% | -100.0% |
| 5 y | 5-year | -98.9% | -100.0% | -98.9% | -100.0% |
| alltime | all time | -98.9% | -100.0% | -98.9% | -100.0% |
Amylyx Pharmaceuticals Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $447.00 K(-98.9%) | $447.00 K(-74.2%) |
| Sep 2024 | - | $1.73 M(-57.7%) |
| Jun 2024 | - | $4.09 M(-79.9%) |
| Mar 2024 | - | $20.35 M(-49.2%) |
| Dec 2023 | $40.05 M | $40.05 M(+36.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $29.35 M(-12.3%) |
| Jun 2023 | - | $33.47 M(+90.7%) |
| Mar 2023 | - | $17.55 M(+14.7%) |
| Dec 2022 | $15.31 M(>+9900.0%) | $15.31 M(>+9900.0%) |
| Sep 2022 | - | $137.00 K(>+9900.0%) |
| Dec 2021 | $0.00 | $0.00 |
FAQ
- What is Amylyx Pharmaceuticals annual accounts receivable?
- What is the all time high annual accounts receivable for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals annual accounts receivable year-on-year change?
- What is Amylyx Pharmaceuticals quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Amylyx Pharmaceuticals?
- What is Amylyx Pharmaceuticals quarterly accounts receivable year-on-year change?
What is Amylyx Pharmaceuticals annual accounts receivable?
The current annual accounts receivable of AMLX is $447.00 K
What is the all time high annual accounts receivable for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high annual accounts receivable is $40.05 M
What is Amylyx Pharmaceuticals annual accounts receivable year-on-year change?
Over the past year, AMLX annual accounts receivable has changed by -$39.60 M (-98.88%)
What is Amylyx Pharmaceuticals quarterly accounts receivable?
The current quarterly accounts receivable of AMLX is $447.00 K
What is the all time high quarterly accounts receivable for Amylyx Pharmaceuticals?
Amylyx Pharmaceuticals all-time high quarterly accounts receivable is $40.05 M
What is Amylyx Pharmaceuticals quarterly accounts receivable year-on-year change?
Over the past year, AMLX quarterly accounts receivable has changed by -$39.60 M (-98.88%)